mskcc.org6d
Imlunestrant Stops Progression of ER+, HER2- Advanced Breast Cancer That Resists Standard Therapy
An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...
mskcc.org6d
Imlunestrant: A Promising Oral Therapy Option for Patients with ER+/HER2- Advanced Breast Cancer
A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...
mskcc.org5d
Miracles on York Avenue: Inspiring Stories from MSK Patients & Staff
From life-saving medicine to gratitude for caregivers and a surprise romance, these stories remind us of the power of human connection.
mskcc.org6d
Tejus A. Bale, MD, PhD
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org3d
Explore DNA Supercoiling in Chromatin Organization and Genome Dynamics
Saturday, March 15, 2025 - 1:00 p.m. to 2:00 p.m.
mskcc.org4d
Lisa R. Allen, MD
Research at MSK Our research impact Research topics Core facilities & resources ...
mskcc.org3d
Age-dependent Alterations in Recombination Compromises Sperm Quality
Wednesday, March 19, 2025 - 1:00 p.m. to 2:00 p.m.
mskcc.org4d
Mechanisms Driving Evolution of Drug Resistance in Lung Cancer
Wednesday, February 26, 2025 - 1:00 p.m. to 2:00 p.m.
mskcc.org6d
RNA Associated Mechanisms in Immune System Development and Function
Wednesday, December 18, 2024 - 1:00 p.m. to 2:00 p.m.
mskcc.org1h
Información sobre las mutaciones en el gen STK11
En esta información se explica de qué manera puede afectarle a usted y a su familia el tener una mutación en el gen STK11.